ReqoData
Biotech & Alternative Protein 2026Updated

List of Precision Fermentation Protein Startups

A curated database of startups using precision fermentation to produce animal-free proteins, including dairy whey, casein, egg albumin, and novel functional proteins. Covers funding details, target proteins, headquarters, and regulatory status for each company.

Available Data Fields

Company Name
Target Protein
Headquarters
Total Funding
Founding Year
Regulatory Status
Host Organism
Production Scale
Key Investors
Website

Data Preview

* Full data requires registration
Company NameTarget ProteinHeadquartersTotal Funding
Perfect DayWhey (beta-lactoglobulin)Berkeley, CA, USA$825M+
The Every CompanyEgg ovalbuminDaly City, CA, USA$294M
RemilkMilk proteins (beta-lactoglobulin)Tel Aviv, Israel$120M
New CultureCaseinSan Francisco, CA, USA$50M+
FormoCasein & whey for cheeseBerlin, Germany$61M+

100+ records available for download.

* Continue from free preview

The Precision Fermentation Protein Landscape

Precision fermentation has emerged as a transformative approach to protein production, using genetically engineered microorganisms — primarily yeast and fungi — to produce specific animal proteins without the animal. The sector has attracted over $2 billion in cumulative venture funding since 2014, with dairy proteins commanding the largest share of investment.

Market Trajectory

The global precision fermentation market was valued at approximately $4.3 billion in 2025 and is projected to exceed $100 billion by 2034, representing a CAGR above 40%. Dairy proteins (whey and casein) account for the most commercially advanced segment, followed by egg proteins and collagen.

Protein Categories Under Development

CategoryKey ProteinsNotable CompaniesRegulatory Progress
Dairy — WheyBeta-lactoglobulin, alpha-lactalbuminPerfect Day, Remilk, ImagindairyFDA GRAS in US; novel food applications in EU
Dairy — CaseinAlpha-s1 casein, kappa-caseinNew Culture, Formo, Standing OvationRegulatory approval pending in most markets
EggOvalbumin, ovotransferrinThe Every Company, Onego BioFDA GRAS (EVERY); EU pending (Onego)
Collagen & GelatinType I & III collagenGeltor, JellatechFDA GRAS for select products
Sweet ProteinsBrazzein, thaumatinOobliFDA GRAS

Scaling Challenges and Breakthroughs

Cost-competitive production remains the sector's central challenge. First-generation companies like Perfect Day initially produced at 10–50x the cost of conventional dairy protein, but continued bioprocess optimization and facility scale-up are narrowing the gap. Perfect Day's upcoming Gujarat facility (expected operational in 2026) and partnerships with co-manufacturers in the US signal the industry's shift from pilot to commercial scale.

Investment Landscape

Funding activity peaked in 2021–2022 but remained active through 2025, with The Every Company closing a $55M Series D and Perfect Day securing $90M in pre-Series E financing. Strategic investors from conventional food (Mars, ADM, Cargill) are increasingly entering the space, reflecting growing confidence in the technology's commercial viability.

Frequently Asked Questions

Q.What protein types are covered in this dataset?

The dataset covers dairy proteins (whey, casein, lactoferrin), egg proteins (ovalbumin), collagen, gelatin, sweet proteins, and other functional proteins produced via precision fermentation. Each entry specifies the target protein and host organism used.

Q.How is the data collected for each startup?

When you request the full dataset, our AI crawls publicly available sources in real time — including company websites, press releases, regulatory filings, and funding databases — to compile the most current information on each company.

Q.Does this include large corporations or only startups?

The focus is on startups and dedicated precision fermentation companies, not large incumbents (e.g., ADM, Cargill) that use fermentation as one of many capabilities. However, spin-offs or dedicated divisions of larger firms are included where relevant.

Q.Can I filter by regulatory approval status?

Yes. You can specify filters for FDA GRAS status, EU novel food authorization, or other regional approvals. Note that regulatory data reflects publicly disclosed information and may not capture pending confidential applications.

Q.How accurate is the funding data?

Funding figures are sourced from public announcements, press releases, and databases like Crunchbase and PitchBook. Undisclosed rounds or confidential extensions may not be reflected.